My research at the Department of Oncology focuses on triple-negative breast cancer and cancer stem cells through the STEM-TNBC study. Utilizing various methods such as cell culture, flow cytometry, patient-derived organoids and cell cultures, and patient line-derived xenografts in zebrafish, I aim to investigate how cancer stem cells are influenced by neoadjuvant chemotherapy administered in clinical practice today.